Why do we need observational studies of everyday patients in the real-life setting?: Table 1

Mesh-Covered Embolic Protection Stent Implantation in ST-Segment-Elevation Myocardial Infarction: Final 1-Year Clinical and Angiographic Results From the MGUARD for Acute ST Elevation Reperfusion Trial

(2015) D. Dudek et al.   Circulation-Cardiovascular Interventions

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

(2014) C M Booth et al.   BRITISH JOURNAL OF CANCER

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

(2014) J. Beyer-Westendorf et al.   EUROPEAN HEART JOURNAL

Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study

(2014) M. Schmidt et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer

(2014) Alexander T. Cohen et al.   THROMBOSIS AND HAEMOSTASIS

A Primer on Effectiveness and Efficacy Trials

(2014) Amit G Singal et al.   Clinical and Translational Gastroenterology

Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation

(2013) Menno V. Huisman et al.   AMERICAN HEART JOURNAL

New oral anticoagulants in elderly patients

(2013) Stefano Barco et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)

(2013) Paulus Kirchhof et al.   EUROPACE

EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary†

(2013) Hein Heidbuchel et al.   EUROPEAN HEART JOURNAL

Current status of clinical background of patients with atrial fibrillation in a community-based survey: The Fushimi AF Registry

(2013) Masaharu Akao et al.   Journal of Cardiology

Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction

(2013) Ole Fröbert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran and Postmarketing Reports of Bleeding

(2013) Mary Ross Southworth et al.   NEW ENGLAND JOURNAL OF MEDICINE

An International Model to Predict Recurrent Cardiovascular Disease

(2012) Peter W.F. Wilson et al.   AMERICAN JOURNAL OF MEDICINE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Cardiovascular registries: a novel platform for randomised clinical trials

(2012) Stefan James et al.   HEART

Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?

(2012) R. A. RODRIGUEZ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Bleeding Risk with Dabigatran in the Frail Elderly

(2012) Paul Harper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

(2012) Jonas Bjerring Olesen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF

(2011) Jonathan P. Piccini et al.   AMERICAN HEART JOURNAL

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)

(2011) Ajay K. Kakkar et al.   AMERICAN HEART JOURNAL

Anticoagulating obese patients in the modern era

(2011) Jignesh P. Patel et al.   BRITISH JOURNAL OF HAEMATOLOGY

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving

(2011) Lau Caspar Thygesen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Dosing of Unfractionated Heparin in Obese Patients with Venous Thromboembolism

(2010) Adam N. Hurewitz et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty

(2010) Michael Rud Lassen et al.   THROMBOSIS AND HAEMOSTASIS

Medication Adherence

(2009) P. Michael Ho et al.   CIRCULATION

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example

(2009) Nigel S. B. Rawson   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Making trials matter: pragmatic and explanatory trials and the problem of applicability

(2009) Shaun Treweek et al.   Trials

Beyond the Randomized Clinical Trial

(2008) Brahmajee K. Nallamothu et al.   CIRCULATION

Evaluating the Evidence

(2008) P. Michael Ho et al.   CIRCULATION

Medication Compliance and Persistence: Terminology and Definitions

(2007) Joyce A. Cramer et al.   VALUE IN HEALTH